Switzerland Plans Major Relaxation of COVID-19 Restrictions – Despite Omicron Rates Among Europe’s Highest 02/02/2022 Elaine Ruth Fletcher Switzerland could be the next European country to lift virtually all COVID restrictions, federal officials said Wednesday – despite warnings from the World Health Organization, headquartered in Geneva, that a total relaxation of the pandemic rules could be premature. In a press briefing on Wednesday, Swiss federal government officials lifted all work-from-home and some quarantine […] Continue reading -> In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> COVAX Update: Enough Vaccines but Big Disparities in Uptake – Exacerbating Risks of New Variants 24/01/2022 Paul Adepoju With the delivery of its one billionth dose last week, COVAX, the WHO co-sponsored vaccine facility, has established itself as the main pillar of vaccine supplies to the world’s 92 poorest economies – providing 82% of the vaccines those nations have received so far. But even as vaccine supplies now ease up, huge disparities persist […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
In Unusual Move, US FDA Invites Pfizer to Request COVID-19 Vaccine Approval for Infants and Toddlers 02/02/2022 Zachary Brennan What does the FDA know that we don’t? Hopefully a lot. Without offering much detail, the FDA yesterday afternoon asked Pfizer to send over a rolling submission to amend its Covid-19 vaccine Emergency Use Authorization to include children 6 months to under 5 years of age. The tricky part in making such a request is […] Continue reading -> Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> COVAX Update: Enough Vaccines but Big Disparities in Uptake – Exacerbating Risks of New Variants 24/01/2022 Paul Adepoju With the delivery of its one billionth dose last week, COVAX, the WHO co-sponsored vaccine facility, has established itself as the main pillar of vaccine supplies to the world’s 92 poorest economies – providing 82% of the vaccines those nations have received so far. But even as vaccine supplies now ease up, huge disparities persist […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Infectious Disease Funding Virtually Unchanged, Neglected Tropical Diseases Continue Trend of Stagnation 28/01/2022 Raisa Santos Despite the strains of COVID-19, global funding for poverty-related infectious diseases, such as HIV/AIDS, TB, and malaria, remains virtually unchanged at US $3.937 billion, with investment dropping only 4% in 2020, according to the fourteenth annual G-FINDER Report. The report, released by Australia-based Policy Cures Research group on Thursday, showed a drop of only US […] Continue reading -> Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> COVAX Update: Enough Vaccines but Big Disparities in Uptake – Exacerbating Risks of New Variants 24/01/2022 Paul Adepoju With the delivery of its one billionth dose last week, COVAX, the WHO co-sponsored vaccine facility, has established itself as the main pillar of vaccine supplies to the world’s 92 poorest economies – providing 82% of the vaccines those nations have received so far. But even as vaccine supplies now ease up, huge disparities persist […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Developing Countries Pledge to Combat Diabetes and Obesity; China & Thailand Suggest Global Targets Are Too Ambitious 27/01/2022 Paul Adepoju In a long and winding discussion Thursday at The World Health Organization’s Executive Board, low- and middle-income countries (LMICs) pledged to redouble their efforts against noncommunicable diseases (NCDs), such as diabetes and obesity, which are having increasing impacts on health and well-being – in addition to infectious diseases that have been at the forefront of […] Continue reading -> COVAX Update: Enough Vaccines but Big Disparities in Uptake – Exacerbating Risks of New Variants 24/01/2022 Paul Adepoju With the delivery of its one billionth dose last week, COVAX, the WHO co-sponsored vaccine facility, has established itself as the main pillar of vaccine supplies to the world’s 92 poorest economies – providing 82% of the vaccines those nations have received so far. But even as vaccine supplies now ease up, huge disparities persist […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Update: Enough Vaccines but Big Disparities in Uptake – Exacerbating Risks of New Variants 24/01/2022 Paul Adepoju With the delivery of its one billionth dose last week, COVAX, the WHO co-sponsored vaccine facility, has established itself as the main pillar of vaccine supplies to the world’s 92 poorest economies – providing 82% of the vaccines those nations have received so far. But even as vaccine supplies now ease up, huge disparities persist […] Continue reading -> As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As WHO Executive Board Meets – Handful of Countries Stall Plans to Reform WHO Finance 23/01/2022 Elaine Ruth Fletcher As the World Health Organization’s executive board meets this week, two major issues – reforming its finances and pandemic response – continue to defy easy consensus. A handful of powerful countries, including but not limited to the United States, remain hesitant over a plan to bolster the World Health Organization’s (WHO) finances by increasing member […] Continue reading -> Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Mixed Reaction in Africa to WHO’s New Position on Booster Shots 22/01/2022 Paul Adepoju IDABAN, Nigeria – The decision of the World Health Organization (WHO) to drop its opposition for COVID-19 vaccination booster shots has raised concerns in Africa about the potential depletion of COVID-19 vaccine doses available to African countries. On Friday, Health Policy Watch reported WHO recommended the wider administration of a third shot of the Pfizer-BioNTech […] Continue reading -> WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Drops Opposition to Boosters – Recommends Third Pfizer Jab for Adults & Two Vaccines for Children Ages 5 & Up 21/01/2022 Elaine Ruth Fletcher In a stark departure from months of booster opposition, WHO on Friday recommended the wider administration of a third shot of the Pfizer-BioNTech mRNA vaccine – as well as jabs for children age 5 and older. The recommendation comes after over 120 countries already have booster campaigns in full-swing, some of them beginning as early […] Continue reading -> Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Italian Lab Study Finds Sputnik V Beat Pfizer’s mRNA Vaccine Against Omicron – Yielding Higher Antibody Levels 21/01/2022 Maayan Hoffman Russia’s Sputnik V demonstrated more than two times higher virus neutralizing activity against the Omicron variant in comparison to the Pfizer coronavirus vaccine, according to a study of blood samples, released Thursday by the National Institute for Infectious Diseases Lazzaro Spallanzani in Italy and Russia’s Gamaleya Center. The research was prepared by a team of […] Continue reading -> Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> Posts navigation Older postsNewer posts